Keating Financial Advisory Services’s Transmedics TMDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.47K Buy
45
+32
+246% +$4.17K ﹤0.01% 1501
2025
Q4
$1.58K Buy
+13
New +$1.63K ﹤0.01% 1658

Other funds holding TMDX

Keating Financial Advisory Services's TMDX Position: Q1 2026 in Review

Keating Financial Advisory Services increased its Transmedics (TMDX) stake by 246% in Q1 2026, buying an estimated $4.17K and bringing the position to 45 shares worth $4.47K. The position accounts for ﹤0.01% of the portfolio, ranked #1501.

Keating Financial Advisory Services first reported a position in TMDX in Q4 2025 and has held it in 2 quarters since. 414 funds tracked by Wall St. Rank hold TMDX as of Q1 2026.

  • Keating Financial Advisory Services held 45 shares of Transmedics worth $4.47K as of Q1 2026.
  • Keating Financial Advisory Services bought 32 Transmedics shares in Q1 2026, an estimated $4.17K.
  • Transmedics made up ﹤0.01% of Keating Financial Advisory Services's portfolio in Q1 2026, its #1501 holding.
  • Keating Financial Advisory Services first reported a position in Transmedics in Q4 2025 and has held it in 2 quarters since.
  • 414 funds tracked by Wall St. Rank held Transmedics as of Q1 2026.

Based on Keating Financial Advisory Services's 13F filing for Q1 2026, filed 15 May 2026.